{"date":"2026-03-09","count":86,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4105-2026-03-09-1942-l7qirp","company_id":"4105","company":"東洋","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"19:42:43","subject":"公告本公司會計主管異動","clause":"第8款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：東洋（4105），2026-03-09 19:42，「公告本公司會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4105-2026-03-09-1941-1f7apel","company_id":"4105","company":"東洋","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"19:41:21","subject":"公告召開本公司115年股東常會事宜","clause":"第17款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：東洋（4105），2026-03-09 19:41，「公告召開本公司115年股東常會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4105-2026-03-09-1940-1cq013a","company_id":"4105","company":"東洋","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"19:40:26","subject":"公告本公司114年第4季合併財務報告","clause":"第31款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：東洋（4105），2026-03-09 19:40，「公告本公司114年第4季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4105-2026-03-09-1939-1mqtn15","company_id":"4105","company":"東洋","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"19:39:18","subject":"公告本公司董事會決議除息基準日事宜","clause":"第14款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：東洋（4105），2026-03-09 19:39，「公告本公司董事會決議除息基準日事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4105-2026-03-09-1937-11wjw0o","company_id":"4105","company":"東洋","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"19:37:10","subject":"公告本公司董事會決議股利分派","clause":"第14款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：東洋（4105），2026-03-09 19:37，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6885-2026-03-09-1915-bwopfv","company_id":"6885","company":"全福生技","market":"上市","industry":"生技醫療","date":"2026-03-09","time":"19:15:56","subject":"公告本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：全福生技（6885），2026-03-09 19:15，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6885-2026-03-09-1915-xo2pc7","company_id":"6885","company":"全福生技","market":"上市","industry":"生技醫療","date":"2026-03-09","time":"19:15:43","subject":"公告本公司董事會決議辦理限制員工權利新股收回註銷減資事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：全福生技（6885），2026-03-09 19:15，「公告本公司董事會決議辦理限制員工權利新股收回註銷減資事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6885-2026-03-09-1915-drgvb6","company_id":"6885","company":"全福生技","market":"上市","industry":"生技醫療","date":"2026-03-09","time":"19:15:30","subject":"公告本公司累積虧損達實收資本額二分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：全福生技（6885），2026-03-09 19:15，「公告本公司累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6885-2026-03-09-1915-1wt2l8m","company_id":"6885","company":"全福生技","market":"上市","industry":"生技醫療","date":"2026-03-09","time":"19:15:12","subject":"公告本公司董事會決議通過114年度合併財務報表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：全福生技（6885），2026-03-09 19:15，「公告本公司董事會決議通過114年度合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6885-2026-03-09-1914-11b1948","company_id":"6885","company":"全福生技","market":"上市","industry":"生技醫療","date":"2026-03-09","time":"19:14:57","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：全福生技（6885），2026-03-09 19:14，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7871-2026-03-09-1836-1t0c2o9","company_id":"7871","company":"安立璽榮-KY","market":"興櫃","industry":"生技醫療","date":"2026-03-09","time":"18:36:44","subject":"代子公司安立璽榮生醫股份有限公司公告轉投資設立美國全資子公司","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安立璽榮-KY（7871），2026-03-09 18:36，「代子公司安立璽榮生醫股份有限公司公告轉投資設立美國全資子公司」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2026-03-09-1832-12h2n4d","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"18:32:55","subject":"公告本公司董事會決議通過設立子公司-室內裝修設計工程股份有限公司(名稱待定)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2026-03-09 18:32，「公告本公司董事會決議通過設立子公司-室內裝修設計工程股份有限公司(名稱待定)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7871-2026-03-09-1831-kiq8nd","company_id":"7871","company":"安立璽榮-KY","market":"興櫃","industry":"生技醫療","date":"2026-03-09","time":"18:31:54","subject":"公告本公司董事會通過2026年(115年)股東常會召開相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安立璽榮-KY（7871），2026-03-09 18:31，「公告本公司董事會通過2026年(115年)股東常會召開相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2026-03-09-1810-11wjw0o","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"18:10:31","subject":"公告本公司董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2026-03-09 18:10，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2026-03-09-1809-148tui6","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-03-09","time":"18:09:40","subject":"本公司與禾榮科技股份有限公司簽署策略聯盟合作意向書","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-03-09 18:09，「本公司與禾榮科技股份有限公司簽署策略聯盟合作意向書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4771-2026-03-09-1809-92x690","company_id":"4771","company":"望隼","market":"上市","industry":"生技醫療","date":"2026-03-09","time":"18:09:13","subject":"董事會決議股利分派","clause":"第14款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：望隼（4771），2026-03-09 18:09，「董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4771-2026-03-09-1809-5j9yh6","company_id":"4771","company":"望隼","market":"上市","industry":"生技醫療","date":"2026-03-09","time":"18:09:00","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第31款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：望隼（4771），2026-03-09 18:09，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4771-2026-03-09-1808-nu21he","company_id":"4771","company":"望隼","market":"上市","industry":"生技醫療","date":"2026-03-09","time":"18:08:38","subject":"公告本公司董事會決議召開115年股東常會相關事宜(異動)","clause":"第17款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：望隼（4771），2026-03-09 18:08，「公告本公司董事會決議召開115年股東常會相關事宜(異動)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4771-2026-03-09-1808-5j9o7v","company_id":"4771","company":"望隼","market":"上市","industry":"生技醫療","date":"2026-03-09","time":"18:08:18","subject":"公告本公司受邀參加凱基證券舉辦之法人說明會","clause":"第12款","fact_date":"2026-03-16","cite_as":"公開資訊觀測站重大訊息：望隼（4771），2026-03-09 18:08，「公告本公司受邀參加凱基證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6857-2026-03-09-1748-1ctgck9","company_id":"6857","company":"宏碁智醫","market":"興櫃","industry":"生技醫療","date":"2026-03-09","time":"17:48:45","subject":"本公司董事會決議不分派股利","clause":"第31款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：宏碁智醫（6857），2026-03-09 17:48，「本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2026-03-09-1746-qwj66v","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"17:46:54","subject":"訂定本公司一一五年度「員工認股權憑證發行及認股辦法」","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2026-03-09 17:46，「訂定本公司一一五年度「員工認股權憑證發行及認股辦法」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2026-03-09-1745-19t4im1","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"17:45:34","subject":"訂定本公司一一五年度「限制員工權利新股發行辦法」","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2026-03-09 17:45，「訂定本公司一一五年度「限制員工權利新股發行辦法」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6857-2026-03-09-1745-11r8ft9","company_id":"6857","company":"宏碁智醫","market":"興櫃","industry":"生技醫療","date":"2026-03-09","time":"17:45:31","subject":"本公司董事會決議召開民國115年股東常會","clause":"第32款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：宏碁智醫（6857），2026-03-09 17:45，「本公司董事會決議召開民國115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2026-03-09-1744-1vss6kp","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"17:44:58","subject":"公告本公司董事會通過114年度員工酬勞及董事酬勞分配案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2026-03-09 17:44，「公告本公司董事會通過114年度員工酬勞及董事酬勞分配案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2026-03-09-1744-11b1948","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"17:44:08","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2026-03-09 17:44，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2026-03-09-1743-ipame9","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"17:43:27","subject":"公告本公司董事會通過114年第四季合併財報","clause":"第31款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2026-03-09 17:43，「公告本公司董事會通過114年第四季合併財報」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6857-2026-03-09-1738-pfpud6","company_id":"6857","company":"宏碁智醫","market":"興櫃","industry":"生技醫療","date":"2026-03-09","time":"17:38:22","subject":"公告本公司董事會決議解除經理人競業禁止限制","clause":"第22款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：宏碁智醫（6857），2026-03-09 17:38，「公告本公司董事會決議解除經理人競業禁止限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6857-2026-03-09-1738-drgvb6","company_id":"6857","company":"宏碁智醫","market":"興櫃","industry":"生技醫療","date":"2026-03-09","time":"17:38:12","subject":"公告本公司累積虧損達實收資本額二分之一","clause":"第44款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：宏碁智醫（6857），2026-03-09 17:38，「公告本公司累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2026-03-09-1736-fqsc9p","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2026-03-09","time":"17:36:17","subject":"本公司董事會決議召開115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2026-03-09 17:36，「本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6857-2026-03-09-1735-a5vf1r","company_id":"6857","company":"宏碁智醫","market":"興櫃","industry":"生技醫療","date":"2026-03-09","time":"17:35:08","subject":"公告本公司董事會決議通過一一四年度合併財務報告","clause":"第43款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：宏碁智醫（6857），2026-03-09 17:35，「公告本公司董事會決議通過一一四年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2026-03-09-1734-md303j","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2026-03-09","time":"17:34:16","subject":"本公司董事會決議不予分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2026-03-09 17:34，「本公司董事會決議不予分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2026-03-09-1731-8f5akg","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2026-03-09","time":"17:31:33","subject":"本公司董事會決議不繼續辦理114年股東常會通過之私募有價證券案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2026-03-09 17:31，「本公司董事會決議不繼續辦理114年股東常會通過之私募有價證券案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2026-03-09-1731-tjxx6d","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2026-03-09","time":"17:31:18","subject":"本公司董事會決議將未符既得條件之限制員工權利新股收回註銷調整資本額","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2026-03-09 17:31，「本公司董事會決議將未符既得條件之限制員工權利新股收回註銷調整資本額」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2026-03-09-1731-111ugd3","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2026-03-09","time":"17:31:07","subject":"本公司董事會決議113年度第1次限制員工權利新股發行及增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2026-03-09 17:31，「本公司董事會決議113年度第1次限制員工權利新股發行及增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2026-03-09-1730-x1jk7d","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2026-03-09","time":"17:30:54","subject":"本公司董事會決議發行115年第1次限制員工權利新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2026-03-09 17:30，「本公司董事會決議發行115年第1次限制員工權利新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2026-03-09-1730-13hmrqq","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2026-03-09","time":"17:30:30","subject":"本公司董事會決議以私募發行有價證券辦理募資","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2026-03-09 17:30，「本公司董事會決議以私募發行有價證券辦理募資」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2026-03-09-1730-w97536","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2026-03-09","time":"17:30:17","subject":"本公司民國114年合併財務報告業經董事會通過","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2026-03-09 17:30，「本公司民國114年合併財務報告業經董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2026-03-09-1723-4bk6fi","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-09","time":"17:23:58","subject":"公告本公司申請「去細胞器官及其製備方法 /ACELLULAR ORGANS, AND METHODS OF PRODUCING THE SAME」專利已取得印度專利核准審定書","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2026-03-09 17:23，「公告本公司申請「去細胞器官及其製備方法 /ACELLULAR ORGANS, AND METHODS OF PRODUC」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2026-03-09-1723-11wjw0o","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2026-03-09","time":"17:23:22","subject":"公告本公司董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2026-03-09 17:23，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2026-03-09-1721-1d29v9p","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"17:21:51","subject":"公告本公司變更股務代理機構事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2026-03-09 17:21，「公告本公司變更股務代理機構事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-5312-2026-03-09-1719-1d29v9p","company_id":"5312","company":"寶島科","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"17:19:26","subject":"公告本公司變更股務代理機構事宜","clause":"第53款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：寶島科（5312），2026-03-09 17:19，「公告本公司變更股務代理機構事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2026-03-09-1714-1b89la1","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"17:14:41","subject":"公告本公司董事會通過114年度財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2026-03-09 17:14，「公告本公司董事會通過114年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2026-03-09-1714-11b1948","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2026-03-09","time":"17:14:16","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2026-03-09 17:14，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2026-03-09-1707-bwopfv","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"17:07:04","subject":"公告本公司董事會決議不分派股利","clause":"第14款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2026-03-09 17:07，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2026-03-09-1704-k37sff","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"17:04:17","subject":"召開115年股東常會相關事宜","clause":"第17款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2026-03-09 17:04，「召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2026-03-09-1701-1lfp08x","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2026-03-09","time":"17:01:23","subject":"公告本公司114年度合併財務報告業經提報董事會通過","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2026-03-09 17:01，「公告本公司114年度合併財務報告業經提報董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4147-2026-03-09-1652-1d29v9p","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"16:52:37","subject":"公告本公司變更股務代理機構事宜","clause":"第53款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2026-03-09 16:52，「公告本公司變更股務代理機構事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2026-03-09-1638-a5b904","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2026-03-09","time":"16:38:13","subject":"本公司受邀參加美國銀行證券舉辦之投資論壇","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2026-03-09 16:38，「本公司受邀參加美國銀行證券舉辦之投資論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2026-03-09-1637-n0me4v","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2026-03-09","time":"16:37:27","subject":"本公司受邀參加華南永昌證券舉辦之投資論壇","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2026-03-09 16:37，「本公司受邀參加華南永昌證券舉辦之投資論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2026-03-09-1636-1wbt819","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2026-03-09","time":"16:36:29","subject":"本公司受邀參加台新證券舉辦之投資論壇","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2026-03-09 16:36，「本公司受邀參加台新證券舉辦之投資論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2026-03-09-1635-pafp1s","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2026-03-09","time":"16:35:23","subject":"本公司受邀參加宏遠證券舉辦之投資論壇","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2026-03-09 16:35，「本公司受邀參加宏遠證券舉辦之投資論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4102-2026-03-09-1628-bwopfv","company_id":"4102","company":"永日","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"16:28:44","subject":"公告本公司董事會決議不分派股利","clause":"第14款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：永日（4102），2026-03-09 16:28，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6762-2026-03-09-1628-nob2a5","company_id":"6762","company":"達亞","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"16:28:27","subject":"公告本公司董事會決議盈餘轉增資發行新股","clause":"第11款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：達亞（6762），2026-03-09 16:28，「公告本公司董事會決議盈餘轉增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4102-2026-03-09-1627-11b1948","company_id":"4102","company":"永日","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"16:27:54","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"第17款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：永日（4102），2026-03-09 16:27，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6762-2026-03-09-1627-4bznrk","company_id":"6762","company":"達亞","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"16:27:26","subject":"公告本公司114年度財務報告經審計委員會同意，並提董事會決議通過","clause":"第31款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：達亞（6762），2026-03-09 16:27，「公告本公司114年度財務報告經審計委員會同意，並提董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6762-2026-03-09-1624-11wjw0o","company_id":"6762","company":"達亞","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"16:24:54","subject":"公告本公司董事會決議股利分派","clause":"第14款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：達亞（6762），2026-03-09 16:24，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4102-2026-03-09-1620-isqttc","company_id":"4102","company":"永日","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"16:20:04","subject":"公告本公司董事會重要決議事項","clause":"第53款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：永日（4102），2026-03-09 16:20，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4102-2026-03-09-1618-5j9yh6","company_id":"4102","company":"永日","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"16:18:51","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第31款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：永日（4102），2026-03-09 16:18，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7773-2026-03-09-1617-1d29v9p","company_id":"7773","company":"富禾生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-09","time":"16:17:34","subject":"公告本公司變更股務代理機構事宜","clause":"第44款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：富禾生醫（7773），2026-03-09 16:17，「公告本公司變更股務代理機構事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4102-2026-03-09-1617-1nnt8f1","company_id":"4102","company":"永日","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"16:17:21","subject":"公告本公司董事會通過解除經理人競業禁止之限制","clause":"第21款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：永日（4102），2026-03-09 16:17，「公告本公司董事會通過解除經理人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-03-09-1605-ajz42i","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-03-09","time":"16:05:15","subject":"依證券商營業處所買賣興櫃股票審查準則第38條第1項第1款和第2款規定，自115年3月13日起停止本公司股票在證券商營業處所買賣。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-03-09 16:05，「依證券商營業處所買賣興櫃股票審查準則第38條第1項第1款和第2款規定，自115年3月13日起停止本公司股票在證券商營業處」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1720-2026-03-09-1559-1d29v9p","company_id":"1720","company":"生達","market":"上市","industry":"生技醫療","date":"2026-03-09","time":"15:59:36","subject":"公告本公司變更股務代理機構事宜","clause":"第51款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：生達（1720），2026-03-09 15:59，「公告本公司變更股務代理機構事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1720-2026-03-09-1558-10yb8rh","company_id":"1720","company":"生達","market":"上市","industry":"生技醫療","date":"2026-03-09","time":"15:58:51","subject":"本公司受邀參加元富證券舉辦之法人說明會","clause":"第12款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：生達（1720），2026-03-09 15:58，「本公司受邀參加元富證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2026-03-09-1546-1u7pahz","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2026-03-09","time":"15:46:51","subject":"董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2026-03-09 15:46，「董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2026-03-09-1543-e6hr0k","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2026-03-09","time":"15:43:12","subject":"公告本公司董事會通過114年度合併財務報表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2026-03-09 15:43，「公告本公司董事會通過114年度合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2026-03-09-1542-137t00g","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2026-03-09","time":"15:42:58","subject":"安特羅董事會決議召開115年股東常會公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2026-03-09 15:42，「安特羅董事會決議召開115年股東常會公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4172-2026-03-09-1537-1mvy42n","company_id":"4172","company":"因華","market":"興櫃","industry":"生技醫療","date":"2026-03-09","time":"15:37:33","subject":"公告本公司董事會決議股利分派情形","clause":"第31款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：因華（4172），2026-03-09 15:37，「公告本公司董事會決議股利分派情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4172-2026-03-09-1535-1howjn","company_id":"4172","company":"因華","market":"興櫃","industry":"生技醫療","date":"2026-03-09","time":"15:35:34","subject":"公告本公司董事會決議召開115年股東常會","clause":"第32款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：因華（4172），2026-03-09 15:35，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7876-2026-03-09-1535-1d29v9p","company_id":"7876","company":"鼎晉生技","market":"興櫃","industry":"生技醫療","date":"2026-03-09","time":"15:35:04","subject":"公告本公司變更股務代理機構事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：鼎晉生技（7876），2026-03-09 15:35，「公告本公司變更股務代理機構事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4172-2026-03-09-1534-drgvb6","company_id":"4172","company":"因華","market":"興櫃","industry":"生技醫療","date":"2026-03-09","time":"15:34:26","subject":"公告本公司累積虧損達實收資本額二分之一","clause":"第44款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：因華（4172），2026-03-09 15:34，「公告本公司累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4172-2026-03-09-1532-1b89la1","company_id":"4172","company":"因華","market":"興櫃","industry":"生技醫療","date":"2026-03-09","time":"15:32:04","subject":"公告本公司董事會通過114年度財務報告","clause":"第43款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：因華（4172），2026-03-09 15:32，「公告本公司董事會通過114年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-03-09-1512-1d29v9p","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"15:12:48","subject":"公告本公司變更股務代理機構事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-03-09 15:12，「公告本公司變更股務代理機構事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6733-2026-03-09-1447-g48d4u","company_id":"6733","company":"博晟生醫","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"14:47:46","subject":"本公司接獲通知「舒效切軟組織處理系統」(SoufCut)取得第二類醫療器材許可證","clause":"第53款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：博晟生醫（6733），2026-03-09 14:47，「本公司接獲通知「舒效切軟組織處理系統」(SoufCut)取得第二類醫療器材許可證」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-03-09-1447-63iwa6","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-03-09","time":"14:47:37","subject":"(補充資訊)本公司受邀參加摩根士丹利證券舉辦之中文線上法人座談會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-03-09 14:47，「(補充資訊)本公司受邀參加摩根士丹利證券舉辦之中文線上法人座談會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3164-2026-03-09-1446-s364tb","company_id":"3164","company":"景岳","market":"上市","industry":"生技醫療","date":"2026-03-09","time":"14:46:40","subject":"公告本公司訂定除息基準日","clause":"第14款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：景岳（3164），2026-03-09 14:46，「公告本公司訂定除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3164-2026-03-09-1446-17rq619","company_id":"3164","company":"景岳","market":"上市","industry":"生技醫療","date":"2026-03-09","time":"14:46:16","subject":"公告本公司董事會114年度每普通股配發現金股利0.8元","clause":"第14款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：景岳（3164），2026-03-09 14:46，「公告本公司董事會114年度每普通股配發現金股利0.8元」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-03-09-1439-17snutz","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"14:39:40","subject":"公告本公司董事會決議召開民國115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-03-09 14:39，「公告本公司董事會決議召開民國115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-03-09-1437-drgvb6","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"14:37:52","subject":"公告本公司累積虧損達實收資本額二分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-03-09 14:37，「公告本公司累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-03-09-1436-1hcai8l","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"14:36:40","subject":"公告本公司董事會決議114年度不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-03-09 14:36，「公告本公司董事會決議114年度不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-03-09-1434-1xwb8pb","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-03-09","time":"14:34:12","subject":"本公司與沛爾生技醫藥股份有限公司簽署策略聯盟合作意向書","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-03-09 14:34，「本公司與沛爾生技醫藥股份有限公司簽署策略聯盟合作意向書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3164-2026-03-09-1432-shvtx9","company_id":"3164","company":"景岳","market":"上市","industry":"生技醫療","date":"2026-03-09","time":"14:32:21","subject":"公告本公司114年第四季合併財務報告提報董事會","clause":"第31款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：景岳（3164），2026-03-09 14:32，「公告本公司114年第四季合併財務報告提報董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2026-03-09-1430-1d29v9p","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"14:30:42","subject":"公告本公司變更股務代理機構事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2026-03-09 14:30，「公告本公司變更股務代理機構事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-03-09-1430-5j9yh6","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"14:30:16","subject":"公告本公司董事會通過 114 年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-03-09 14:30，「公告本公司董事會通過 114 年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3164-2026-03-09-1425-o2ryr2","company_id":"3164","company":"景岳","market":"上市","industry":"生技醫療","date":"2026-03-09","time":"14:25:09","subject":"公告本公司董事會決議通過114年度董事及員工酬勞分派","clause":"第51款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：景岳（3164），2026-03-09 14:25，「公告本公司董事會決議通過114年度董事及員工酬勞分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1788-2026-03-09-1424-1d29v9p","company_id":"1788","company":"杏昌","market":"上櫃","industry":"生技醫療","date":"2026-03-09","time":"14:24:27","subject":"公告本公司變更股務代理機構事宜","clause":"第53款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：杏昌（1788），2026-03-09 14:24，「公告本公司變更股務代理機構事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3164-2026-03-09-1420-11b1948","company_id":"3164","company":"景岳","market":"上市","industry":"生技醫療","date":"2026-03-09","time":"14:20:52","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"第17款","fact_date":"2026-03-09","cite_as":"公開資訊觀測站重大訊息：景岳（3164），2026-03-09 14:20，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}